Profile | GDS2987 / GI_6005869-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 5 | 19 |
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 15.2 | 45 |
GSM215254 | HMVEC_atorvastatin_rep1 | 12.8 | 33 |
GSM215282 | HMVEC_atorvastatin_rep3 | 5.6 | 13 |
GSM215344 | HMVEC_atorvastatin_rep2 | 16 | 38 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 27.5 | 42 |
GSM215294 | HMVEC_SLx2119_rep1 | 10.2 | 35 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 5.9 | 10 |
GSM215297 | PASMC_vehicle_rep1 | 1785.3 | 96 |
GSM215298 | PASMC_vehicle_rep2 | 1414.8 | 95 |
GSM215310 | PASMC_vehicle_rep3 | 1220.9 | 95 |
GSM215311 | PASMC_atorvastatin_rep1 | 1062.4 | 94 |
GSM215312 | PASMC_atorvastatin_rep2 | 1141.8 | 94 |
GSM215313 | PASMC_atorvastatin_rep3 | 1302.7 | 95 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 1259.8 | 95 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 1245 | 95 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 1094.6 | 94 |
GSM215327 | PASMC_SLx2119_rep1 | 452.8 | 88 |
GSM215328 | PASMC_SLx2119_rep2 | 382.8 | 87 |
GSM215329 | PASMC_SLx2119_rep3 | 423 | 88 |
GSM215330 | Fibroblasts_vehicle_rep1 | 4.2 | 10 |
GSM215331 | Fibroblasts_vehicle_rep2 | ||
GSM215332 | Fibroblasts_vehicle_rep3 | ||
GSM215333 | Fibroblasts_atorvastatin_rep1 | 6.2 | 17 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | ||
GSM215335 | Fibroblasts_atorvastatin_rep3 | 12 | 29 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 3.8 | 13 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 17.5 | 48 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 8 | 22 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 17.9 | 46 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 1.1 | 3 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 2.6 | 7 |